Reports
Sale
Global Chronic Disease Management Market Size, Share, Trends: By Type: Solution, Services; By Solution Type: On-Premise Solution, Cloud-Based Solution; By Service Type; Educational Service, Implementation Service, Consulting Service, Others; By Disease Indication; End User; Regional Analysis; Patent Analysis; Supplier Landscape; 2024-2032
Global Chronic Disease Management Market Outlook
The global chronic disease management market size was valued at USD 5.8 billion in 2023, driven by the increasing prevalence of chronic diseases across the globe. The market size is anticipated to grow at a CAGR of 14.4% during the forecast period of 2024-2032, with values likely to rise from USD 6.7 billion in 2024 and to USD 19.5 billion by 2032.
Chronic Disease Management: Introduction
Chronic diseases are health conditions that persist over a long period of time and do not go away. They can last for years or even a lifetime. Examples of chronic diseases include cardiovascular disease, diabetes, osteoporosis, arthritis, multiple sclerosis, lupus, and asthma.
Chronic disease management involves your doctor taking your full medical history and current medical status into account. Based on this information, your physician can recommend a treatment plan tailored to your specific condition.
Managing a chronic disease involves more than just simple blood tests or treating symptoms. It aims to reduce symptoms while controlling the disease and its progression. Additionally, one health condition may be causing or significantly impacting another health condition. Understanding this relationship can help you and your doctor manage the disease effectively.
Global Chronic Disease Management Market Analysis
There have been several initiatives by the government towards the support of chronic disease management systems that are influencing the market growth. For example, a Chronic Disease Management Act (CDMA) was introduced in the United States Senate. This bill is an expansion on previous versions of CDMA and follows 2019 guidance issued by the U.S. Department of Treasury to further increase the flexibility of HSA-HDHPs to cover chronic disease services on a pre-deductible basis.
The increasing number of discoveries and development of new drugs for adults suffering from chronic disease are under development, driving the global chronic disease management market growth. For example, ALZ-801, an amyloid beta-protein inhibitor, is in phase III trial for adult patients suffering from Alzheimer’s disease.
A new report from the World Health Organization (WHO) has mentioned that non-communicable diseases, or NCDs, account for nearly three-quarters of deaths each year.
The increasing prevalence of chronic diseases such as diabetes, cancer, and cardiovascular diseases across the globe is a major threat for healthcare systems to take suitable actions to avoid the increasing number of deaths associated with such medical conditions. For instance, the data released by the World Health Organization (WHO) predicted that if NCDs kept on increasing continuously, chronic diseases such as cardiovascular diseases, cancer, diabetes, and respiratory illnesses are expected to account for nearly 86 percent of the 90 million deaths each year, which is a whopping 90 percent increase in absolute numbers, since 2019.
Global Chronic Disease Management Market Segmentations
Market Breakup by Type
- Solution
- Services
Market Breakup by Solution Type
- On-Premise Solution
- Cloud-Based Solution
Market Breakup by Service Type
- Educational Service
- Implementation Service
- Consulting Service
- Others
Market Breakup by Disease Indication
- Cardiovascular Diseases (CVD)
- Diabetes
- Chronic Obstructive Pulmonary Disorders (COPD)
- Arthritis
- Asthma
- Cancer
- Others
Market Breakup by End User
- Healthcare Providers
- Healthcare Payers
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Chronic Disease Management Market Overview
The growth of the market is driven by the continuously rising prevalence of chronic diseases such as cancer, cardiovascular disease, and diabetes, among others. With the increasing geriatric population, young adults are experiencing frequent exacerbations due to the declining quality of their lives, increasing the demand for chronic disease management. The increasing popularity of chronic disease management is a major factor contributing to the global chronic disease management market share.
Chronic diseases are responsible for the death of approximately 41 million people each year, accounting for about 74% of the global deaths. Several studies show that the mortality rates of potentially preventable chronic diseases are higher in low-income countries as compared to high-income countries. Such data exhibits the urgency of establishing chronic disease management policies and programs with proper regulation. Furthermore, increasing strategic initiatives such as mergers, collaborations, and acquisitions by leading players, are the key factors providing chronic disease management market growth.
North America is likely to lead the global market during the forecast period due to the presence of a geriatric population and the increasing adoption of a sedentary lifestyle leading to chronic diseases.
Global Chronic Disease Management Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- WellSky
- ZeOmega
- Health Catalyst
- Cedar Gate Technologies
- Cognizant
- Pegasystems Inc.
- Epic Systems Corporation
- Hinduja Global Solutions Ltd.
- NXGN Management, LLC
- MINES & Associates, Inc.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Solution Type |
|
| Breakup by Service Type |
|
| Breakup by Disease Indication |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Chronic Disease Management Market Overview
3.1 Global Chronic Disease Management Market Historical Value (2017-2023)
3.2 Global Chronic Disease Management Market Forecast Value (2024-2032)
4 Global Chronic Disease Management Market Landscape
4.1 Global Chronic Disease Management: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Chronic Disease Management: Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Applications
5 Global Chronic Disease Management Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Chronic Disease Management Market Segmentation
6.1 Global Chronic Disease Management Market by Type
6.1.1 Market Overview
6.1.2 Solution
6.1.3 Services
6.2 Global Chronic Disease Management Market by Solution Type
6.2.1 Market Overview
6.2.2 On-Premise Solution
6.2.3 Cloud-Based Solution
6.3 Global Chronic Disease Management Market by Service Type
6.3.1 Market Overview
6.3.2 Educational Service
6.3.3 Implementation Service
6.3.4 Consulting Service
6.3.5 Others
6.4 Global Chronic Disease Management Market by Disease Indication
6.4.1 Market Overview
6.4.2 Cardiovascular Diseases (CVD)
6.4.3 Diabetes
6.4.4 Chronic Obstructive Pulmonary Disorders (COPD)
6.4.5 Arthritis
6.4.6 Asthma
6.4.7 Cancer
6.4.8 Others
6.5 Global Chronic Disease Management Market by End User
6.5.1 Market Overview
6.5.2 Healthcare Providers
6.5.3 Healthcare Payers
6.5.4 Others
6.6 Global Chronic Disease Management Market by Region
6.6.1 Market Overview
6.6.2 North America
6.6.3 Europe
6.6.4 Asia Pacific
6.6.5 Latin America
6.6.6 Middle East and Africa
7 North America Chronic Disease Management Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Chronic Disease Management Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Global Chronic Disease Management Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Chronic Disease Management Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Chronic Disease Management Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 WellSky
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 ZeOmega
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Health Catalyst
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Cedar Gate Technologies
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Cognizant
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Pegasystems Inc.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Epic Systems Corporation
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Hinduja Global Solutions Ltd.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 NXGN Management, LLC
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 MINES & Associates, Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
19 Company Competitiveness Analysis (Additional Insight)
19.1 Very Small Companies
19.2 Small Companies
19.3 Mid-Sized Companies
19.4 Large Companies
19.5 Very Large Companies
20 Payment Methods (Additional Insight)
20.1 Government Funded
20.2 Private Insurance
20.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about USD 5.8 billion in 2023, driven by increasing research activities.
The market is anticipated to grow at a CAGR of 14.4% during the forecast period of 2024-2032, likely to reach a market value of USD 19.5 billion by 2032.
The increasing prevalence of chronic diseases and the increasing geriatric population are the key factors driving the market growth.
The increasing awareness about chronic disease management and government initiatives are among the major trends influencing the market growth.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa.
Chronic disease management includes solutions and services.
The solutions provided are on-premises solutions and cloud-based solutions.
Services provided are educational services, implementation services, and consulting services, among others.
End users in the market are healthcare providers and healthcare payers, among others.
Key players involved in the market are WellSky, ZeOmega, Health Catalyst, Cedar Gate Technologies, Cognizant, Pegasystems Inc., Hinduja Global Solutions Ltd., NXGN Management, LLC, MINES & Associates, Inc., and Epic Systems Corporation.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$ 3499
$1999
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5999
$2999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 7999
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 9999
$5999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER